No profile data available.
BioNexus Gene Lab Corp. (BGLC) is a manufacturing and production company in the chemical supplies wholesale industry, based in Kuala Lumpur, Malaysia, with about 19 full-time employees.
It reported revenue of $7.42 million for fiscal year 2025, down 21.9% from fiscal year 2024, and net income of -$2.98 million. Its largest business segment, Trading of Industrial Chemicals, brought in 100% of segment revenue in fiscal year 2025; Malaysia was the largest region with 79%. Its market capitalization was $3.78 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia.
BioNexus Gene Lab reported $7.42 million in revenue for fiscal year 2025, down 21.9% from $9.51 million in fiscal year 2024.
Trading of Industrial Chemicals, with $7.41 million or 100% of segment revenue in fiscal year 2025. Next: Provision for Genomic Screening Services (under 1%).
Malaysia: 79% of revenue by region in fiscal year 2025, followed by Maldives (9%).
$3.78 million as of October 9, 2026.
Listed companies of a similar size in the same industry (chemical supplies wholesale) include Hudson Technologies, Inc. (HDSN).